Arcus Biosciences Email Format

Biotechnology
501-1,000 employees
Hayward, CA, USA

Arcus Biosciences is a clinical-stage biopharmaceutical company developing differentiated cancer therapies and combination medicines to address areas of high unmet medical need.

Find contacts at Arcus Biosciences

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@arcusbio.com

Company Overview

Industry
Biotechnology
Founded
2015
Headquarters
Hayward, CA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Key Executives
Terry Rosen (Chief Executive Officer), Bob Goeltz (Chief Financial Officer)

Tech Stack

Marketo

Marketing

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Arcus Biosciences?

Arcus Biosciences uses the firstinitiallast format on arcusbio.com, so Jane Smith would be jsmith@arcusbio.com.

What cancer indications does Arcus Biosciences focus on in its clinical pipeline?

Arcus Biosciences focuses primarily on oncology, with late-stage programs targeting kidney cancer, pancreatic cancer, and lung cancer. Its lead candidates include casdatifan, quemliclustat, and domvanalimab, all being evaluated in Phase 2 or Phase 3 trials.

How does Arcus Biosciences work with Gilead Sciences on its drug development programs?

Arcus Biosciences and Gilead Sciences have a 10-year collaboration established in 2020 to co-develop oncology candidates including zimberelimab and domvanalimab, with Gilead holding commercialization rights outside the U.S. and both companies sharing co-promotion rights in the U.S. if approved.

Who leads Arcus Biosciences as CEO?

Terry Rosen serves as the Chief Executive Officer of Arcus Biosciences. The company, headquartered in Hayward, California, has around 655 employees and is listed on the NYSE under the ticker RCUS.

Does Arcus Biosciences have programs outside of oncology?

Yes, Arcus Biosciences has an inflammation and immunology pipeline that includes small-molecule programs targeting conditions such as atopic dermatitis, rheumatoid arthritis, psoriasis, multiple sclerosis, and systemic lupus erythematosus. Tools like Clay can help you find the right Arcus contact for business development outreach in these areas.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles